Naloxone Hydrochloride Injection, Solution
Product Images NDC 0409-1219

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 0409-1219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Naloxone Hydrochloride (Naloxone 01)

HCl is a chemical formula that represents hydrochloric acid, a strong and highly corrosive acid commonly used in industrial processes and laboratory experiments. It is a colorless, pungent solution of hydrogen chloride in water and is one of the most common acids found in the human body, playing a role in digestion as well as maintaining the pH balance.*

FDA Label Image

Logo (Naloxone 02)

FDA Label Image

Principal Display Panel (1 mL Vial Label)

This is a description of a NALOXONE HCI Injection, USP 0.4 mg/mL with NDC number 0409-1215-21. It is a single-dose injection to be administered via L.V, LLM, or S.C. route and should be protected from light. This drug is available only with a prescription and is distributed by Hospira, Inc. It also includes a code, possibly representing a lot number or expiration date.*

FDA Label Image

Principal Display Panel (1 mL Vial Carton)

This is a description of a medication called Naloxone Hydrochloride injection, USP Rxonly which comes in a 1mL single-dose Fliptop Vial (with 0.4 mg/mL concentration) and is used for intravenous, intramuscular or subcutaneous use. It is sterile and nonpyrogenic and has a tonicity of 0.31 mOsmol/mL (calc.) and pH 4.0 (3.0 to 6.5). It should be stored at 20 to 25°C (68 to 77°F) and protected from light. The lot number is CA7231 and it is distributed by Hospirs, Laks Forest, L 60AS USA.*

FDA Label Image

Principal Display Panel (10 mL Vial Label)

This is a description of a prescription drug in a multiple-dose vial. The vial contains 10 mL of sterile, nonpyrogenic solution of Naloxone HCI USP. The solution has been supplemented with sodium chloride solution to achieve isotonicity. The solution has a strength of 4 mg/10 mL (0.4 mg/mL). The drug is meant for intravenous, intramuscular or subcutaneous use. It should be protected from light and stored at 68-77°F. The vial has been distributed by Hospira Inc, based in Lake Forest, IL. A LOT number and an EXP date have been provided on the label.*

FDA Label Image

Principal Display Panel (10 mL Vial Carton)

This is a label of Naloxone Hydrochloride Injection, USP. It has 4 mg/10 mL (0.4 mg/mL) concentration and is used for intravenous, intramuscular, or subcutaneous use. The usual dosage of the injection should be checked on the insert. It is sterile and nonpyrogenic and must be stored at 68 to 77°F (20 to 25°C). The medication must be kept away from light sources and should be kept in the original carton until used. The solution has methylparaben and propylparaben preservatives. It includes sodium chloride to adjust tonicity and may contain HCl for pH adjustment.*

FDA Label Image

Principal Display Panel (1 mL Ampul Label)

This is a description of a medication labeled NDC 0409-1212-01, which is Naloxone HCI injection with a strength of 0.4 mg/mL. It is recommended to protect the medication from light and can be used intravenously, intramuscularly or subcutaneously. The medication is manufactured by Hospira, Inc. located in Lake Forest, IL 60045 USA.*

FDA Label Image

Principal Display Panel (1 mL Ampul Tray)

The text is a description of Naloxone Hydrochloride injection, USP, which comes in 1mL, 10 Single-dose Ampuls. Each ampul contains 0.4 mg of naloxone hydrochloride, and it is for LM, LV or S.C. use. It is recommended to keep the ampuls in a tray to protect them from light until the time of use. The pH is adjusted with hydrochloric acid, and the usual dosage and other important information can be found in the insert. The recommended storage temperature is 20 to 25°C, and it should be kept at controlled room temperature only. Copyright for Hospira 2004 is also noted.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.